The Checkup by Singlecare
DECEMBER 6, 2023
Is Xifaxan covered by insurance? | How much does Xifaxan cost without insurance? | How to get Xifaxan without insurance Xifaxan is a brand-name prescription drug approved by the Food and Drug Administration (FDA) to treat irritable bowel syndrome with diarrhea (IBS-D), traveler’s diarrhea, and overt hepatic encephalopathy (OHE).
The Checkup by Singlecare
AUGUST 23, 2023
Is Janumet covered by insurance? | How much does Janumet cost without insurance? | How to get Janumet without insurance Janumet is a brand-name prescription drug that combines two diabetes medications: metformin and sitagliptin. A generic version of sitagliptin may be available as early as 2026 or as late as 2029.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
JANUARY 16, 2023
Is Glyxambi covered by insurance? | How much does Glyxambi cost without insurance? | How to get Glyxambi without insurance. Generic Glyxambi could be available by 2029 , but this is not guaranteed. . Is Glyxambi covered by insurance? How much does Glyxambi cost without insurance? SingleCare price.
Pharmaceutical Technology
APRIL 12, 2023
On 30 March 2023, a US District Court judge issued a final judgment ruling that struck down a portion of the Affordable Care Act’s (ACA’s) requirement for most private insurance plans to cover many preventive services. Without assistance, PrEP can cost thousands of dollars per year.
Pharmaceutical Technology
JULY 15, 2022
In April, the US House of Representatives passed the Affordable Insulin Act, which set a price cap of $35 a month for Medicare and private insurance users. Type 1 diabetes (T1D) is forecast to affect five million people in the eight major pharmaceutical markets, which are the US, France, Germany, Italy, Spain, UK, Japan, and Canada, by 2029.
pharmaphorum
JUNE 14, 2022
Analysts at Clarivate have said that the US market for alopecia therapies could reach $1.7billion in 2029, with JAK drugs accounting for the biggest share. Olumiant is also approved to treat rheumatoid arthritis and some hospitalised patients with COVID-19, and made more than $1.1 billion from its approved indications last year.
Fuld
JULY 27, 2021
It has announced plans to install 4,000 primary care “supercenters” in its stores by 2029. These will include primary care, laboratory testing services, X-rays, and dental, eye, and ear care, as well as health insurance. Walmart had been planning for an even more ambitious move into healthcare.
Expert insights. Personalized for you.
52 
Let's personalize your content